跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
RYEQO 40/1/0.5 relugolix 40 mg/estradiol 1 mg/norethisterone acetate 0.5 mg film coated tablet blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
RYEQO 40/1/0.5 relugolix 40 mg/estradiol 1 mg/norethisterone acetate 0.5 mg film coated tablet blister pack
Approved
STANDARD
RYEQO 40/1/0.5 relugolix 40 mg/estradiol 1 mg/norethisterone acetate 0.5 mg film coated tablet blister pack
Gedeon Richter Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Oct 26, 2025
Approval ID
c5ea28fdb45e05bf
Company
Gedeon Richter Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
c5ea28fdb45e05bf
Product Name
RYEQO 40/1/0.5 relugolix 40 mg/estradiol 1 mg/norethisterone acetate 0.5 mg film coated tablet blister pack
Artg Id
500887
Artg Name
RYEQO 40/1/0.5 relugolix 40 mg/estradiol 1 mg/norethisterone acetate 0.5 mg film coated tablet blister pack
Sponsor
Gedeon Richter Australia Pty Ltd
Company Detail Path
/organization/gedeon-richter-australia-pty-ltd
Artg Date
2025-10-24
Registration Type
Medicine
Therapeutic Good Type
Medicines
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Oct 26, 2025
Approval ID
c5ea28fdb45e05bf
Type
Standard
Back to TGA Approvals